Incannex Healthcare Inc. Retained Earnings
Incannex Healthcare Inc. (IXHL) had Retained Earnings of -$174.37 million as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-05-15
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$174.37M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$170.48M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$163.96M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$157.56M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-03-31 | -$174.37M 10-Q · filed 2026-05-15 |
| 2025-12-31 | -$170.48M 10-Q · filed 2026-02-13 |
| 2025-09-30 | -$163.96M 10-Q · filed 2025-11-14 |
| 2025-06-30 | -$157.56M 10-Q · filed 2026-05-15 |
| 2025-03-31 | -$125.95M 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$121.98M 10-Q · filed 2025-02-14 |
| 2024-09-30 | -$116.09M 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$110.67M 10-K · filed 2025-09-29 |
| 2024-03-31 | -$104.21M 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$98.18M 10-Q · filed 2024-02-14 |
| 2023-06-30 | -$92.21M 10-K · filed 2024-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B |